NBIX position history
The shares of Neurocrine Biosciences (NBIX) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q1: 13,334 shares, $1.5M, 0.28% of portfolio, New
- 2025 Q2: 13,334 shares, $1.7M, 0.36% of portfolio
- 2025 Q3: 18,117 shares, $2.5M, 0.47% of portfolio, Add +35.9%
- 2025 Q4: 18,117 shares, $2.6M, 0.36% of portfolio
- 2026 Q1: 18,117 shares, $2.4M, 0.37% of portfolio
- 2026 Q2: 18,117 shares, $3.1M, 0.42% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|